Mitarbeiter Athlet Gründer trougakos ioannis Adler Hochland Beleben
Frontiers | Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection | Immunology
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications | Journal of Biomedical Science | Full Text
Genentech: Baris Bingol | Principal Scientist, Neuroscience
Universal Design: A Step toward Successful Aging – topic of research paper in Psychology. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications | Journal of Biomedical Science | Full Text
Loop | Ioannis Trougakos
Olive Bioactives: applications and prospects | LE STUDIUM
Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model | Aging
Correlation plots between the rate of change (RC) in the (%) inhibition... | Download Scientific Diagram
Ioannis Trougakos
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn
How to pronounce Ioannis P Trougakos | HowToPronounce.com
Biomedicine Archives - Page 2 of 3 - Neuro-Psychology
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
The Speakers – ICSA 2019 Athens
Vaccines | Free Full-Text | SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response
Age‐dependent and gender‐dependent antibody responses against SARS‐CoV‐2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine - Terpos - 2021 - American Journal of Hematology - Wiley Online Library
PDF) Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors
Identification of new biomarkers and therapeutic targets for MDR tumours - Stratagem
Cardiotoxicity Due to Proteasome Dysfunction | Bioimaging-GR, Virtual Laboratory
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment - Abstract - Europe PMC
Prof. Ioannis P. TROUGAKOS – Mu.Ta.Lig – COST ACTION CA15135
Comparison of neutralizing antibody responses against SARS‐CoV‐2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier? - Terpos - 2021 -